{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:43:56Z","timestamp":1768877036554,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","award":["FRGS\/1\/2020\/SKK01\/UM\/02\/2"],"award-info":[{"award-number":["FRGS\/1\/2020\/SKK01\/UM\/02\/2"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s13318-025-00964-1","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T06:36:40Z","timestamp":1757659000000},"page":"515-528","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development and Validation of an HPLC-MS\/MS Method for Quantitative Bioanalysis of Lidocaine and its Metabolites in Human Plasma: Application in a Population Pharmacokinetic Study"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3188-864X","authenticated-orcid":false,"given":"Keng Wah","family":"Foong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5061-0646","authenticated-orcid":false,"given":"Didi Erwandi","family":"Mohamad Haron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3886-6435","authenticated-orcid":false,"given":"Sook Hui","family":"Chaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5521-2543","authenticated-orcid":false,"given":"Yoke Lin","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noridayu","family":"Omer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3819-1602","authenticated-orcid":false,"given":"Pui San","family":"Loh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,12]]},"reference":[{"key":"964_CR1","doi-asserted-by":"publisher","unstructured":"Gordh T. Lidocaine: the origin of a modern local anesthetic. 1949. Anesthesiology. 2010;113:1433-7. https:\/\/doi.org\/10.1097\/ALN.0b013e3181fcef48.","DOI":"10.1097\/ALN.0b013e3181fcef48"},{"key":"964_CR2","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/anae.15270","volume":"76","author":"I Foo","year":"2021","unstructured":"Foo I, Macfarlane AJR, Srivastava D, Bhaskar A, Barker H, Knaggs R, et\u00a0al. The use of intravenous lidocaine for postoperative pain and recovery: international consensus statement on efficacy and safety. Anaesthesia. 2021;76:238\u201350. https:\/\/doi.org\/10.1111\/anae.15270.","journal-title":"Anaesthesia"},{"key":"964_CR3","doi-asserted-by":"crossref","first-page":"216","DOI":"10.64719\/pb.4391","volume":"50","author":"R Chu","year":"2020","unstructured":"Chu R, Umukoro N, Greer T, Roberts J, Adekoya P, Odonkor CA, et\u00a0al. Intravenous lidocaine infusion for the management of early postoperative pain: a comprehensive review of controlled trials. Psychopharmacol Bull. 2020;50:216\u201359.","journal-title":"Psychopharmacol Bull"},{"key":"964_CR4","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.bja.2019.06.014","volume":"123","author":"H Hermanns","year":"2019","unstructured":"Hermanns H, Hollmann MW, Stevens MF, Lirk P, Brandenburger T, Piegeler T, et\u00a0al. Molecular mechanisms of action of systemic lidocaine in acute and chronic pain: a narrative review. Br J Anaesth. 2019;123:335\u201349. https:\/\/doi.org\/10.1016\/j.bja.2019.06.014.","journal-title":"Br J Anaesth"},{"key":"964_CR5","unstructured":"Bauer LA. Lidocaine. Applied Clinical Pharmacokinetics, 3e. New York, NY: McGraw-Hill Medical; 2015."},{"key":"964_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0021-9673(99)00415-x","volume":"854","author":"LD Bo","year":"1999","unstructured":"Bo LD, Mazzucchelli P, Marzo A. Highly sensitive bioassay of lidocaine in human plasma by high-performance liquid chromatography-tandem mass spectrometry. J Chromatogr A. 1999;854:3\u201311. https:\/\/doi.org\/10.1016\/s0021-9673(99)00415-x.","journal-title":"J Chromatogr A"},{"issue":"5","key":"964_CR7","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/chromsci\/44.5.262","volume":"44","author":"Z Chik","year":"2006","unstructured":"Chik Z, Lee TD, Holt DW, Johnston A, Tucker AT. Validation of high-performance liquid chromatographic-mass spectrometric method for the analysis of lidocaine in human plasma. J Chromatogr Sci. 2006;44(5):262\u20135. https:\/\/doi.org\/10.1093\/chromsci\/44.5.262.","journal-title":"J Chromatogr Sci"},{"key":"964_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2019.121793","volume":"1129","author":"B van Domburg","year":"2019","unstructured":"van Domburg B, van der Nagel BCH, Andrews LM, Koch BCP. High-throughput quantification of ten antiarrhythmic drugs in human plasma using UPLC-MS\/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2019;1129: 121793. https:\/\/doi.org\/10.1016\/j.jchromb.2019.121793.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"964_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/s0378-4347(00)00054-2","volume":"741","author":"M Abdel-Rehim","year":"2000","unstructured":"Abdel-Rehim M, Bielenstein M, Askemark Y, Tyrefors N, Arvidsson T. High-performance liquid chromatography-tandem electrospray mass spectrometry for the determination of lidocaine and its metabolites in human plasma and urine. J Chromatogr B Biomed Sci Appl. 2000;741:175\u201388. https:\/\/doi.org\/10.1016\/s0378-4347(00)00054-2.","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"964_CR10","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1093\/chromsci\/bmw051","volume":"54","author":"G Saluti","year":"2016","unstructured":"Saluti G, Giusepponi D, Moretti S, Di Salvo A, Galarini R. Flexible method for analysis of lidocaine and its metabolite in biological fluids. J Chromatogr Sci. 2016;54:1193\u2013200. https:\/\/doi.org\/10.1093\/chromsci\/bmw051.","journal-title":"J Chromatogr Sci"},{"key":"964_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jchromb.2011.11.030","volume":"881","author":"E ter Weijden","year":"2012","unstructured":"ter Weijden E, van den Broek MP, Ververs FF. Easy and fast LC-MS\/MS determination of lidocaine and MEGX in plasma for therapeutic drug monitoring in neonates with seizures. J Chromatogr B Analyt Technol Biomed Life Sci. 2012;881:111\u20134. https:\/\/doi.org\/10.1016\/j.jchromb.2011.11.030.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"964_CR12","first-page":"696","volume":"41","author":"J Xiang","year":"2010","unstructured":"Xiang J, Zhang C, Yu Q, Liang MZ, Qin YP. Nan F [Determination of lidocaine and its metabolites in human plasma by liquid chromatography in combination with tandem mass spectrometry]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2010;41:696\u20139.","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"964_CR13","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jchromb.2007.01.010","volume":"852","author":"A Maes","year":"2007","unstructured":"Maes A, Weiland L, Sandersen C, Gasthuys F, De Backer P, Croubels S. Determination of lidocaine and its two N-desethylated metabolites in dog and horse plasma by high-performance liquid chromatography combined with electrospray ionization tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;852:180\u20137. https:\/\/doi.org\/10.1016\/j.jchromb.2007.01.010.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"964_CR14","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.clinbiochem.2016.05.001","volume":"49","author":"M Shipkova","year":"2016","unstructured":"Shipkova M, Svinarov D. Lc-ms\/ms as a tool for TDM services: where are we? Clin Biochem. 2016;49:1009\u201323. https:\/\/doi.org\/10.1016\/j.clinbiochem.2016.05.001.","journal-title":"Clin Biochem"},{"key":"964_CR15","unstructured":"Food and Drug Administration. Bioanalytical Method Validation Guidance for Industry. In: U.S. Department of Health and Human Services, editor.: U.S. Department of Health and Human Services; 2018. Available from: https:\/\/www.fda.gov\/media\/70858\/download."},{"key":"964_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s40543-018-0160-2","author":"SS Sonawane","year":"2019","unstructured":"Sonawane SS, Chhajed SS, Attar SS, Kshirsagar SJ. An approach to select linear regression model in bioanalytical method validation. J Anal Sci Technol. 2019. https:\/\/doi.org\/10.1186\/s40543-018-0160-2.","journal-title":"J Anal Sci Technol"},{"key":"964_CR17","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). Integrated addendum to ICH E6(R1): guideline for good clinical practice E6(R2). Step 4 version. 9 November 2016. Available from: https:\/\/database.ich.org\/sites\/default\/files\/E6_R2_Addendum.pdf."},{"key":"964_CR18","unstructured":"National Committee for Clinical Research. Malaysian Guideline for Good Clinical Practice. 4th ed: National Pharmaceutical Regulatory Agency (NPRA); 2018. Available from: https:\/\/npra.gov.my\/images\/Guidelines_Central\/Guidelines_on_Clinical_Trial\/MalaysianGuidelineforGoodClinicalPractice.pdf."},{"key":"964_CR19","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association. World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191\u20134. https:\/\/doi.org\/10.1001\/jama.2013.281053.","journal-title":"JAMA"},{"key":"964_CR20","unstructured":"Phenomenex. Gemini C6-phenyl HPLC columns. 2025. Available from: https:\/\/www.phenomenex.com\/products\/gemini-hplc-column\/gemini-c6-phenyl."},{"key":"964_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.4409","volume":"33","author":"A Tan","year":"2019","unstructured":"Tan A, Fanaras JC. Use of high-pH (basic\/alkaline) mobile phases for LC-MS or LC-MS\/MS bioanalysis. Biomed Chromatogr. 2019;33: e4409. https:\/\/doi.org\/10.1002\/bmc.4409.","journal-title":"Biomed Chromatogr"},{"key":"964_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2022.123362","volume":"1207","author":"Y Jin","year":"2022","unstructured":"Jin Y, He C, Di X, Fu L, Qi X, Liu R, et\u00a0al. Simultaneous determination of lidocaine and its active metabolites in plasma by UPLC-MS\/MS and application to a clinical pharmacokinetic study in liver cancer patients with laparoscopic hepatectomy. J Chromatogr B Analyt Technol Biomed Life Sci. 2022;1207: 123362. https:\/\/doi.org\/10.1016\/j.jchromb.2022.123362.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"964_CR23","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s11095-025-03835-1","volume":"42","author":"KW Foong","year":"2025","unstructured":"Foong KW, Loh PS, Chaw SH, Lo YL. Population pharmacokinetics of IV lidocaine and its metabolites in adult surgical patients. Pharm Res. 2025;42:451\u201373. https:\/\/doi.org\/10.1007\/s11095-025-03835-1.","journal-title":"Pharm Res"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-025-00964-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13318-025-00964-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-025-00964-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:04:06Z","timestamp":1761127446000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13318-025-00964-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["964"],"URL":"https:\/\/doi.org\/10.1007\/s13318-025-00964-1","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,12]]},"assertion":[{"value":"19 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they do not have any conflict of interest relevant to this work. The authors report there are no competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the UMMC Medical Research Ethics Committee (ID: 201972-7589)","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}}]}}